To assess cellular immunity against Omicron, a recent study evaluated minimal crossover between mutations with the Omicron variant of SARS-CoV-2 and CD8 T-cell epitopes found in individuals recovering from COVID-19, suggesting that the cellular response to CD8 T-cell early infection must still be effective against the new variant (22). Here, CD8A is linked to COVID-19.